Revolution Medicines Inc annual earnings per share (EPS) for fiscal TTM was $-7.14, a decrease of 20.0% from $-5.95 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-7.14 | $-5.95 | $-3.58 | $-3.86 | $-3.08 | $-2.57 | $-1.62 | $-1.31 | $-1.15 | $-0.85 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-2.29 | $-1.92 | $-1.61 | $-1.32 | $-1.13 | $-1.16 | $-0.94 | $-0.81 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RVMD metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All RVMD financial statements → Interactive RVMD charts →
About TickerBase · Data methodology & sources